97 related articles for article (PubMed ID: 8906107)
41. Immunotherapy attenuates eosinophil transendothelial migration induced by the supernatants of antigen-stimulated mononuclear cells from atopic asthmatics.
Nagata M; Saito K; Kikuchi I; Tabe K; Hagiwara K; Kanazawa M; Sakamoto Y
Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():21-4. PubMed ID: 15166479
[TBL] [Abstract][Full Text] [Related]
42. Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.
Gosset P; Prin L; Capron M; Auriault C; Tonnel AB; Capron A
Clin Exp Immunol; 1986 Sep; 65(3):654-63. PubMed ID: 3780047
[TBL] [Abstract][Full Text] [Related]
43. Immunological response to Parthenium hysterophorus in Indian Patients with Parthenium sensitive atopic dermatitis.
Kumar S; Khandpu S; Rao DN; Wahaab S; Khanna N
Immunol Invest; 2012; 41(1):75-86. PubMed ID: 22091625
[TBL] [Abstract][Full Text] [Related]
44. Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes.
Yamada H; Matsukura M; Yudate T; Chihara J; Stingl G; Tezuka T
Int Arch Allergy Immunol; 1997 Oct; 114 Suppl 1():28-32. PubMed ID: 9363921
[TBL] [Abstract][Full Text] [Related]
45. Enhancement of intestinal eosinophilia during Hymenolepis nana infection in mice.
Niwa A; Miyazato T
J Helminthol; 1996 Mar; 70(1):33-41. PubMed ID: 8960197
[TBL] [Abstract][Full Text] [Related]
46. Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis.
Kim HS; Kim JH; Seo YM; Chun YH; Yoon JS; Kim HH; Lee JS; Kim JT
Ann Allergy Asthma Immunol; 2017 Nov; 119(5):441-445. PubMed ID: 28866306
[TBL] [Abstract][Full Text] [Related]
47. Association between serum IL-16 levels and the degree of sensitization in patients with atopic dermatitis.
Nagy G; Gáspár K; Irinyi B; Gál M; Tumpek J; Gyimesi E; Sipka S; Remenyik É; Szodoray P; Szegedi A
Int Arch Allergy Immunol; 2011; 156(1):69-74. PubMed ID: 21447961
[TBL] [Abstract][Full Text] [Related]
48. Predictors of atopic dermatitis severity over time.
Ben-Gashir MA; Seed PT; Hay RJ
J Am Acad Dermatol; 2004 Mar; 50(3):349-56. PubMed ID: 14988674
[TBL] [Abstract][Full Text] [Related]
49. Isolation of chicken eosinophils and their migration response in chick embryos.
Moriya O; Ichikawa Y
Dev Comp Immunol; 1982; 6(4):717-26. PubMed ID: 6186538
[TBL] [Abstract][Full Text] [Related]
50. Eosinophil chemotactic response to rat CGRP-1 is increased after exposure to trypsin or guinea-pig lung particulate fraction.
Manley HC; Haynes LW
Neuropeptides; 1989 Jan; 13(1):29-34. PubMed ID: 2784198
[TBL] [Abstract][Full Text] [Related]
51. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K).
Mishra RK; Scaife JE; Harb Z; Gray BC; Djukanovic R; Dent G
Allergy; 2005 Sep; 60(9):1204-7. PubMed ID: 16076309
[TBL] [Abstract][Full Text] [Related]
52. Cutaneous eosinophil accumulation in atopic and non-atopic individuals: the effect of an ECF-A tetrapeptide and histamine.
Bryant DH; Kay AB
Clin Allergy; 1977 May; 7(3):211-7. PubMed ID: 332409
[TBL] [Abstract][Full Text] [Related]
53. Chemotactic activity of soluble extract of Schistosoma japonicum eggs for human and monkey eosinophils.
Horii Y; Matsuoka H; Owhashi M
Z Parasitenkd; 1986; 72(4):557-9. PubMed ID: 3751234
[No Abstract] [Full Text] [Related]
54. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P
Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011
[TBL] [Abstract][Full Text] [Related]
55. Defective monocyte and polymorphonuclear leukocyte chemotaxis and clinical characteristics in atopic dermatitis.
Ternowitz T; Herlin T
Arch Dermatol Res; 1986; 278(6):454-9. PubMed ID: 3789804
[TBL] [Abstract][Full Text] [Related]
56. Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes.
Czarnetzki BM
Immunobiology; 1980 Apr; 157(1):62-6. PubMed ID: 6782008
[TBL] [Abstract][Full Text] [Related]
57. Chronologic analysis of eosinophil granule protein deposition and cell adhesion molecule expression in mite allergen-induced dermatitis in atopic subjects.
Wakugawa M; Nakagawa H; Yamada N; Tamaki K
Int Arch Allergy Immunol; 1996; 111 Suppl 1():5-11. PubMed ID: 8906103
[TBL] [Abstract][Full Text] [Related]
58. Chemical mediators and adhesion molecules involved in eosinophil accumulation in vivo.
Weg VB; Williams TJ
Ann N Y Acad Sci; 1994 May; 725():146-55. PubMed ID: 8030986
[No Abstract] [Full Text] [Related]
59. Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity.
Goto T; Morioka J; Inamura H; Yano M; Kodaira K; Igarashi Y; Abe S; Kurosawa M
Allergol Int; 2007 Dec; 56(4):433-8. PubMed ID: 17965582
[TBL] [Abstract][Full Text] [Related]
60. Serum eosinophil chemotactic factor levels in patients with bullous pemphigoid, drug reactions and atopic eczema.
Czarnetzki BM; Kalveram KJ; Dierksmeier U
J Invest Dermatol; 1979 Aug; 73(2):163-5. PubMed ID: 156767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
